204 related articles for article (PubMed ID: 20452681)
1. Tumor-infiltrating, myeloid-derived suppressor cells inhibit T cell activity by nitric oxide production in an intracranial rat glioma + vaccination model.
Jia W; Jackson-Cook C; Graf MR
J Neuroimmunol; 2010 Jun; 223(1-2):20-30. PubMed ID: 20452681
[TBL] [Abstract][Full Text] [Related]
2. Tumor infiltration by myeloid suppressor cells in response to T cell activation in rat gliomas.
Graf MR; Sauer JT; Merchant RE
J Neurooncol; 2005 May; 73(1):29-36. PubMed ID: 15933813
[TBL] [Abstract][Full Text] [Related]
3. Irradiated tumor cell vaccine for treatment of an established glioma. I. Successful treatment with combined radiotherapy and cellular vaccination.
Graf MR; Prins RM; Hawkins WT; Merchant RE
Cancer Immunol Immunother; 2002 Jun; 51(4):179-89. PubMed ID: 12012105
[TBL] [Abstract][Full Text] [Related]
4. GM-CSF promotes the immunosuppressive activity of glioma-infiltrating myeloid cells through interleukin-4 receptor-α.
Kohanbash G; McKaveney K; Sakaki M; Ueda R; Mintz AH; Amankulor N; Fujita M; Ohlfest JR; Okada H
Cancer Res; 2013 Nov; 73(21):6413-23. PubMed ID: 24030977
[TBL] [Abstract][Full Text] [Related]
5. Irradiated tumor cell vaccine for treatment of an established glioma. II. Expansion of myeloid suppressor cells that promote tumor progression.
Prins RM; Scott GP; Merchant RE; Graf MR
Cancer Immunol Immunother; 2002 Jun; 51(4):190-9. PubMed ID: 12012106
[TBL] [Abstract][Full Text] [Related]
6. Mammary tumor heterogeneity in the expansion of myeloid-derived suppressor cells.
Donkor MK; Lahue E; Hoke TA; Shafer LR; Coskun U; Solheim JC; Gulen D; Bishay J; Talmadge JE
Int Immunopharmacol; 2009 Jul; 9(7-8):937-48. PubMed ID: 19362167
[TBL] [Abstract][Full Text] [Related]
7. Tumor-infiltrating myeloid-derived suppressor cells are pleiotropic-inflamed monocytes/macrophages that bear M1- and M2-type characteristics.
Umemura N; Saio M; Suwa T; Kitoh Y; Bai J; Nonaka K; Ouyang GF; Okada M; Balazs M; Adany R; Shibata T; Takami T
J Leukoc Biol; 2008 May; 83(5):1136-44. PubMed ID: 18285406
[TBL] [Abstract][Full Text] [Related]
8. Glioma-derived galectin-1 regulates innate and adaptive antitumor immunity.
Verschuere T; Toelen J; Maes W; Poirier F; Boon L; Tousseyn T; Mathivet T; Gerhardt H; Mathieu V; Kiss R; Lefranc F; Van Gool SW; De Vleeschouwer S
Int J Cancer; 2014 Feb; 134(4):873-84. PubMed ID: 23929302
[TBL] [Abstract][Full Text] [Related]
9. Antiangiogenic drugs synergize with a membrane macrophage colony-stimulating factor-based tumor vaccine to therapeutically treat rats with an established malignant intracranial glioma.
Jeffes EW; Zhang JG; Hoa N; Petkar A; Delgado C; Chong S; Obenaus A; Sanchez R; Khalaghizadeh S; Khomenko T; Knight BA; Alipanah R; Nguyen TV; Shah C; Vohra S; Zhuang JL; Liu J; Wepsic HT; Jadus MR
J Immunol; 2005 Mar; 174(5):2533-43. PubMed ID: 15728459
[TBL] [Abstract][Full Text] [Related]
10. Cytotoxic T cells infiltrating a glioma express an aberrant phenotype that is associated with decreased function and apoptosis.
Prins RM; Graf MR; Merchant RE
Cancer Immunol Immunother; 2001 Aug; 50(6):285-92. PubMed ID: 11570581
[TBL] [Abstract][Full Text] [Related]
11. Elevated levels of polymorphonuclear myeloid-derived suppressor cells in patients with glioblastoma highly express S100A8/9 and arginase and suppress T cell function.
Gielen PR; Schulte BM; Kers-Rebel ED; Verrijp K; Bossman SA; Ter Laan M; Wesseling P; Adema GJ
Neuro Oncol; 2016 Sep; 18(9):1253-64. PubMed ID: 27006175
[TBL] [Abstract][Full Text] [Related]
12. Glial TIM-3 Modulates Immune Responses in the Brain Tumor Microenvironment.
Kim HS; Chang CY; Yoon HJ; Kim KS; Koh HS; Kim SS; Lee SJ; Kane LP; Park EJ
Cancer Res; 2020 May; 80(9):1833-1845. PubMed ID: 32094297
[TBL] [Abstract][Full Text] [Related]
13. Glioma-specific cytotoxic T cells can be effectively induced by subcutaneous vaccination of irradiated wild-type tumor cells without artificial cytokine production.
Iwadate Y; Yamaura A; Sakiyama S; Sato Y; Tagawa M
Int J Oncol; 2003 Aug; 23(2):483-8. PubMed ID: 12851699
[TBL] [Abstract][Full Text] [Related]
14. 70-kDa heat shock protein coated magnetic nanocarriers as a nanovaccine for induction of anti-tumor immune response in experimental glioma.
Shevtsov MA; Nikolaev BP; Yakovleva LY; Parr MA; Marchenko YY; Eliseev I; Yudenko A; Dobrodumov AV; Zlobina O; Zhakhov A; Ischenko AM; Pitkin E; Multhoff G
J Control Release; 2015 Dec; 220(Pt A):329-340. PubMed ID: 26522072
[TBL] [Abstract][Full Text] [Related]
15. Skewing the Th cell phenotype toward Th1 alters the maturation of tumor-infiltrating mononuclear phagocytes.
Nonaka K; Saio M; Suwa T; Frey AB; Umemura N; Imai H; Ouyang GF; Osada S; Balazs M; Adany R; Kawaguchi Y; Yoshida K; Takami T
J Leukoc Biol; 2008 Sep; 84(3):679-88. PubMed ID: 18566103
[TBL] [Abstract][Full Text] [Related]
16. Loss of SOCS3 in myeloid cells prolongs survival in a syngeneic model of glioma.
McFarland BC; Marks MP; Rowse AL; Fehling SC; Gerigk M; Qin H; Benveniste EN
Oncotarget; 2016 Apr; 7(15):20621-35. PubMed ID: 26967393
[TBL] [Abstract][Full Text] [Related]
17. CD8+ T cell-independent tumor regression induced by Fc-OX40L and therapeutic vaccination in a mouse model of glioma.
Murphy KA; Erickson JR; Johnson CS; Seiler CE; Bedi J; Hu P; Pluhar GE; Epstein AL; Ohlfest JR
J Immunol; 2014 Jan; 192(1):224-33. PubMed ID: 24293627
[TBL] [Abstract][Full Text] [Related]
18. Dendritic Cell-Based Vaccines that Utilize Myeloid Rather than Plasmacytoid Cells Offer a Superior Survival Advantage in Malignant Glioma.
Dey M; Chang AL; Miska J; Wainwright DA; Ahmed AU; Balyasnikova IV; Pytel P; Han Y; Tobias A; Zhang L; Qiao J; Lesniak MS
J Immunol; 2015 Jul; 195(1):367-76. PubMed ID: 26026061
[TBL] [Abstract][Full Text] [Related]
19. Myeloid derived suppressor cell infiltration of murine and human gliomas is associated with reduction of tumor infiltrating lymphocytes.
Raychaudhuri B; Rayman P; Huang P; Grabowski M; Hambardzumyan D; Finke JH; Vogelbaum MA
J Neurooncol; 2015 Apr; 122(2):293-301. PubMed ID: 25579983
[TBL] [Abstract][Full Text] [Related]
20. Depletion of regulatory T cells in a mouse experimental glioma model through anti-CD25 treatment results in the infiltration of non-immunosuppressive myeloid cells in the brain.
Maes W; Verschuere T; Van Hoylandt A; Boon L; Van Gool S
Clin Dev Immunol; 2013; 2013():952469. PubMed ID: 23710206
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
